NFE2L2 and pancreatic neoplasm: Accumulating evidence suggests that p62 is an important oncoprotein 45-47, particularly in pancreatic cancer, where p62 promotes tumor progression by stabilizing NRF2, which modulates the stress response and malignant phenotype 46.